Lab reportSponsored
PT-141
PT-141 1
PT-141 2

Reported purity99.985%

Task number#150804

Tested22 APR 2026

VerificationReport available

View report
Product information

About PT-141

Research product

99.985% purity — independently analysed

Sulan Bio PT-141 batch SUL0330-001 was independently analysed by Janoshik Laboratory under task #150804.

The analytical report recorded 99.985% purity and 10.10mg measured content for the submitted 10mg sample, providing batch-specific analytical documentation for this marketplace listing.

What is PT-141?

PT-141, also known as Bremelanotide, is a synthetic peptide and melanocortin receptor agonist. It is structurally related to the melanocortin peptide family and is primarily studied for its interactions with melanocortin receptors within central signalling pathways.

PT-141 is particularly associated with research involving the MC3R and MC4R melanocortin receptors. These receptor systems participate in a range of neurological, behavioural and neuroendocrine signalling processes.

Common research areas

PT-141 / Bremelanotide is commonly investigated in laboratory and neuroendocrine research examining:

  • Melanocortin receptor signalling
  • MC3R and MC4R receptor activity
  • Central nervous system signalling pathways
  • Neuroendocrine regulation
  • Behavioural and motivational signalling
  • Sexual-behaviour and arousal pathways in experimental models
  • Hypothalamic signalling mechanisms
  • Melanocortin peptide and receptor pharmacology

PT-141 and melanocortin receptor research

The melanocortin system consists of several receptor subtypes involved in diverse physiological signalling pathways. PT-141 is of particular research interest because its activity is associated with central melanocortin receptors rather than a direct peripheral vascular mechanism.

This makes PT-141 relevant to experimental studies investigating how melanocortin receptor activation influences neural, behavioural and neuroendocrine signalling.

Available configuration

  • Strength: 10mg per vial
  • Box configuration: 10 vials
  • MOQ: 10 vials / 1 box
  • Format: Lyophilized research peptide
  • Supplier: Sulan Bio

Batch verification

  • Supplier: Sulan Bio
  • Batch: SUL0330-001
  • Reported purity: 99.985%
  • Measured content: 10.10mg
  • Tested strength: 10mg
  • Independent laboratory: Janoshik
  • Task number: #150804
  • Tested: 22 APR 2026
  • COA status: Available
Research use only

This product is supplied strictly for laboratory research and analytical applications. It is not intended for human consumption, medical use, diagnostic use or clinical application.

Purity99.985%

Format10MG

MOQ10 vials / 1 box

Ships fromChina

Product verification

Laboratory report

Report linked
Reported purity99.985%Analytical result shown in the supplied report.
Task number#150804
Tested22 APR 2026
Report typeJanoshik / COA
Unique IDTVWLBRAXZ2KR
Verification documentLaboratory report preview
Full report
PT-141 verification report
Research use only

This listing is provided for laboratory and research sourcing review. It is not intended for human consumption, medical use or self-administration.

From$48.00
Buy now